NEJMの9月6日号、今月30日で期限切れになるSCHIPの再承認をめぐって議論になっている問題をPerspectiveで取り上げています。
Reauthorization of the State Children's Health Insurance Program (SCHIP), which was considered a routine matter until recently because of the program's success in expanding coverage to children of the working poor, has become embroiled in a larger struggle over ideologies that divide the political parties.
http://content.nejm.org/cgi/content/extract/357/10/957
以下も無料記事です。
Sidelining Safety — The FDA's Inadequate Response to the IOM
Having been commissioned by the Food and Drug Administration (FDA) to evaluate the U.S. drug-safety system, the Institute of Medicine (IOM) published a report, The Future of Drug Safety, in September 2006 identifying weaknesses in the laws, regulations, resources, and practice of ensuring drug safety.
http://content.nejm.org/cgi/content/extract/357/10/960
コメント